4.5 Article

Bone mass in schizophrenia and normal populations across different decades of life

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Hormone predictors of bone mineral density changes during the menopausal transition

MR Sowers et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Article Pharmacology & Pharmacy

Antipsychotic drugs - A new risk factor for osteoporosis in young women with schizophrenia?

V O'Keane et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)

Article Clinical Neurology

Management of hyperprolactinemia in patients receiving antipsychotics

KK Miller

CNS SPECTRUMS (2004)

Article Endocrinology & Metabolism

Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents

U Naidoo et al.

PSYCHONEUROENDOCRINOLOGY (2003)

Article Neurosciences

Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia

M Bilici et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2002)

Review Endocrinology & Metabolism

The use of ultrasound in the assessment of bone status

S Gonnelli et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)

Article Endocrinology & Metabolism

Quantitative ultrasound of bone in male osteoporosis

D Mulleman et al.

OSTEOPOROSIS INTERNATIONAL (2002)

Article Endocrinology & Metabolism

Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis

ML Frost et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2001)

Article Endocrinology & Metabolism

Clinical performance of a highly portable, scanning calcaneal ultrasonometer

SL Greenspan et al.

OSTEOPOROSIS INTERNATIONAL (2001)